Characterization of gut microbiota associated with metabolic syndrome and type-2 diabetes mellitus in Mexican pediatric subjects

• Published in: BMC pediatrics Vol. 23; no. 1; pp. 210 - 13
• Main Authors: Carrizales-Sánchez, Ana K., Tamez-Rivera, Oscar, Rodríguez-Gutiérrez, Nora A., Elizondo-Montemayor, Leticia, Gradilla-Hernández, Misael Sebastián, García-Rivas, Gerardo, Pacheco, Adriana, Senés-Guerrero, Carolina
• Format: Journal Article
• Language: English
• Published: London BioMed Central 03.05.2023; BioMed Central Ltd; BMC
• Subjects: Adolescent; Bacteria; Bacteria - genetics; Biomarkers; Child; Complications and side effects; Composition; Diabetes; Diabetes Mellitus; Diabetes Mellitus, Type 2; Gastrointestinal Microbiome; Gut microbiota; Humans; Insulin resistance; Internal Medicine; Medicine; Medicine & Public Health; Metabolic diseases; Metabolic Syndrome; Metabolic Syndrome X; Microbiota; Microbiota (Symbiotic organisms); Obesity; Obesity in children; Pediatric Obesity; Pediatrics; Prevention; Risk factors; RNA, Ribosomal, 16S - genetics; Statistical significance; Taxonomy; Teenagers; Type 2 diabetes; Type II; United States; Gut microbiota; Type II; Metabolic Syndrome X; Diabetes Mellitus; Child; Adolescent
• ISSN: 1471-2431; 1471-2431
• DOI: 10.1186/s12887-023-03983-6

Background Childhood obesity is a serious public health concern that confers a greater risk of developing important comorbidities such as MetS and T2DM. Recent studies evidence that gut microbiota may be a contributing factor; however, only few studies exist in school-age children. Understanding the potential role of gut microbiota in MetS and T2DM pathophysiology from early stages of life might contribute to innovative gut microbiome-based interventions that may improve public health. The main objective of the present study was to characterize and compare gut bacteria of T2DM and MetS children against control subjects and determine which microorganisms might be potentially related with cardiometabolic risk factors to propose gut microbial biomarkers that characterize these conditions for future development of pre-diagnostic tools. Results Stool samples from 21 children with T2DM, 25 with MetS, and 20 controls ( n  = 66) were collected and processed to conduct 16S rDNA gene sequencing. α- and β-diversity were studied to detect microbial differences among studied groups. Spearman correlation was used to analyze possible associations between gut microbiota and cardiometabolic risk factors, and linear discriminant analyses (LDA) were conducted to determine potential gut bacterial biomarkers. T2DM and MetS showed significant changes in their gut microbiota at genus and family level. Read relative abundance of Faecalibacterium and Oscillospora was significantly higher in MetS and an increasing trend of Prevotella and Dorea was observed from the control group towards T2DM. Positive correlations were found between Prevotella , Dorea , Faecalibacterium , and Lactobacillus with hypertension, abdominal obesity, high glucose levels, and high triglyceride levels. LDA demonstrated the relevance of studying least abundant microbial communities to find specific microbial communities that were characteristic of each studied health condition. Conclusions Gut microbiota was different at family and genus taxonomic levels among controls, MetS, and T2DM study groups within children from 7 to 17 years old, and some communities seemed to be correlated with relevant subjects’ metadata. LDA helped to find potential microbial biomarkers, providing new insights regarding pediatric gut microbiota and its possible use in the future development of gut microbiome-based predictive algorithms.